Skyrocketing Cancer Drug Prices Can Oncologists Influence Policy Abstract The rapid escalation of cancer drug prices has emerged as a major challenge in contemporary oncology practice, with many newly approved therapies carrying annual costs that exceed one hundred thousand dollars per patient. This
